Sol-Gel Technologies Ltd. (SLGL)
68.19
-1.44
(-2.07%)
USD |
NASDAQ |
Oct 27, 16:00
70.96
+2.77
(+4.06%)
After-Hours: 20:00
Sol-Gel Technologies Enterprise Value : 176.10M for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 176.10M |
| October 26, 2026 | 180.81M |
| October 23, 2026 | 180.22M |
| October 22, 2026 | 173.48M |
| October 21, 2026 | 168.01M |
| October 20, 2026 | 168.30M |
| October 19, 2026 | 165.59M |
| October 16, 2026 | 163.20M |
| October 15, 2026 | 177.76M |
| October 14, 2026 | 180.38M |
| October 13, 2026 | 176.46M |
| October 12, 2026 | 189.88M |
| October 09, 2026 | 187.82M |
| October 08, 2026 | 183.13M |
| October 07, 2026 | 188.39M |
| October 06, 2026 | 200.49M |
| October 05, 2026 | 211.32M |
| October 02, 2026 | 188.57M |
| October 01, 2026 | 191.84M |
| September 30, 2026 | 196.03M |
| September 29, 2026 | 189.39M |
| September 28, 2026 | 180.22M |
| September 25, 2026 | 171.71M |
| September 24, 2026 | 151.70M |
| September 23, 2026 | 148.33M |
| Date | Value |
|---|---|
| September 22, 2026 | 152.39M |
| September 21, 2026 | 146.92M |
| September 18, 2026 | 149.28M |
| September 17, 2026 | 164.14M |
| September 16, 2026 | 160.54M |
| September 15, 2026 | 163.69M |
| September 14, 2026 | 166.24M |
| September 11, 2026 | 168.73M |
| September 10, 2026 | 171.51M |
| September 09, 2026 | 179.34M |
| September 08, 2026 | 179.96M |
| September 04, 2026 | 180.45M |
| September 03, 2026 | 182.35M |
| September 02, 2026 | 183.43M |
| September 01, 2026 | 180.45M |
| August 31, 2026 | 179.07M |
| August 28, 2026 | 178.12M |
| August 27, 2026 | 190.44M |
| August 26, 2026 | 212.89M |
| August 25, 2026 | 220.39M |
| August 24, 2026 | 206.22M |
| August 21, 2026 | 207.33M |
| August 20, 2026 | 209.83M |
| August 19, 2026 | 210.14M |
| August 18, 2026 | 212.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 60.28B |
| RedHill Biopharma Ltd. | -11.14M |
| MediWound Ltd. | 136.22M |
| Purple Biotech Ltd. | -4.534M |
| PolyPid Ltd. | 112.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.681M |
| Revenue (Quarterly) | 0.591M |
| Total Expenses (Quarterly) | 4.272M |
| EPS Diluted (Quarterly) | -1.126 |
| Profit Margin (Quarterly) | -622.8% |
| Earnings Yield | -8.28% |
| Normalized Earnings Yield | -8.278 |